I think the FDA guidance possibly was misunderstood by many insofar that the FDA was giving an open checkbook to companies, they weren't. COVID-19 is a new virus. The FDA not letting testing devices be sold to professionals unless they pass efficacy standards. It is impressive to see speed the FDA is reviewing big and small pharma company's products in the COVID-19 space. It is a pace that has never been seen before. So that bodes well for companies that deliver excellence.